New Issue: Goldman Sachs prices $20 million 5.45% trigger notes exchangeable for Pfizer

New York, March 9 - The Goldman Sachs Group Inc. priced $20 million of one-year 5.45% trigger notes mandatorily exchangeable for the common stock of Pfizer Inc., according to a 424B3 filing with the Securities and Exchange Commission.

Issuer:	Goldman Sachs Group Inc.
Underlying stock:	Pfizer Inc.
Issue:	Trigger mandatory exchangeable medium-term notes
Amount:	$20 million
Maturity:	March 13, 2006
Coupon:	5.45%, payable quarterly
Price:	Par of $26.652
Payout at maturity:	1 share of Pfizer stock per $26.652 principal amount, capped at $29.317 or 110% above initial stock price of $26.652, in cash or stock at Goldman's option; if market price does not fall below threshold price, then payout has a floor of par, in cash or stock at Goldman's option
Threshold price:	$21.855, 82% of initial price of $26.652
Call:	Non-callable
Pricing date:	March 3
Settlement date:	March 10

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.